Attached files
| file | filename |
|---|---|
| EX-10.12 - EX-10.12 - Regulus Therapeutics Inc. | d842033dex1012.htm |
| EX-10.14 - EX-10.14 - Regulus Therapeutics Inc. | d842033dex1014.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Regulus Therapeutics Inc. | Financial_Report.xls |
| EX-32.1 - EX-32.1 - Regulus Therapeutics Inc. | d842033dex321.htm |
| EX-31.2 - EX-31.2 - Regulus Therapeutics Inc. | d842033dex312.htm |
| EX-10.16 - EX-10.16 - Regulus Therapeutics Inc. | d842033dex1016.htm |
| 10-K - 10-K - Regulus Therapeutics Inc. | d842033d10k.htm |
| EX-31.1 - EX-31.1 - Regulus Therapeutics Inc. | d842033dex311.htm |
| EX-10.15 - EX-10.15 - Regulus Therapeutics Inc. | d842033dex1015.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 No. 333-333-194293) of Regulus Therapeutics Inc., and
(2) Registration Statement (Form S-8 Nos. 333-184324, 333-188606 and 333-194294) pertaining to the 2009 Equity Incentive Plan, 2012 Equity Incentive Plan and the 2012 Employee Stock Purchase Plan of Regulus Therapeutics Inc.;
of our report dated February 18, 2015, with respect to the financial statements of Regulus Therapeutics Inc. included in this Annual Report (Form 10-K) of Regulus Therapeutics Inc. for the year ended December 31, 2014.
/s/ Ernst & Young LLP
San Diego, California
February 18, 2015